Trials / Sponsors / Savient Pharmaceuticals
Savient Pharmaceuticals
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis Chronic Kidney Disease Stage 5 | Phase 1 | 2012-12-01 |
| Completed | Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients Chronic Gout Refractory to Conventional Therapy | Phase 3 | 2008-05-01 |
| Completed | Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptoma Gout | Phase 3 | 2006-12-01 |
| Completed | Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout Gout | Phase 3 | 2006-05-01 |
| Completed | A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy Gout | Phase 2 | 2004-03-01 |
| Terminated | Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients HIV, Peripheral Nervous System Disorders | Phase 2 | 2003-09-01 |